🚨 BREAKING NEWS: The @fda.gov has granted traditional approval to brexucabtagene autoleucel for the treatment of adult patients with relapsed/refractory mantle cell lymphoma. #oncology #MCL #hematology
Here's what you should know about the decision: www.onclive.com/view/fda-app...